Shares in this Australian stem cell company are going nuts on an investment … – Business Insider Australia
Brisbane Times |
Shares in this Australian stem cell company are going nuts on an investment …
Business Insider Australia The US company will also get a six-month right of first refusal on Mesoblast’s proprietary adult stem cell product candidates for the prevention and treatment of acute graft versus host disease, certain cancers, inflammatory bowel diseases and organ … Mesoblast Shares Climb as Celgene Invests $45 MillionBloomberg Mesoblast takes partnership with Celgene, shares rise 27pcSydney Morning Herald Celgene And Mesoblast Enter Into Equity Placement and Right of First Refusal …GlobeNewswire (press release) Nasdaq all 22 news articles » |
|
Dr. Salvatore Iaquinta’s Highway to Health: Can stem cells be the answer to …
Marin Independent Journal And if stem cells are truly the pluripotent panacea we’ve been looking for, why are researchers bothering with baldness? Shouldn’t we be growing new kidneys to prevent transplants and dialysis? Regenerating damaged spinal cords to get the paralyzed up … |
San Angelo Standard Times |
Stem cell therapy for dogs draws support, detractors
San Angelo Standard Times Instead, his veterinarian told him about a newly available procedure involving stem cells. In a single day, the vet said, they could remove the cells from Cookie’s fatty tissues, process them and re-inject them into her joints. She could go home … |
|
Expert to discuss impact of investing in stem cell research
Bradenton Herald LINCOLN, Neb. — At the next Lincoln Science Cafe, the president and CEO of the California Institute for Regenerative Medicine will discuss the impact of investing in stem cell research. Before joining the institute last year, C. Randal Mills was … |